1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Nonthavej Hospital Public Company Limited

Nonthavej Hospital Public Company Limited

NTV.BK
Nonthavej Hospital Public Company LimitedTH flagStock Exchange of Thailand
18.90
THB
+0.20
- -
3.02BMarket Cap
Nonthavej Hospital Public Company Limited
NTV.BK
(Stock Exchange of Thailand)

Recent

price

18.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.64
9.06
10.76
11.13
11.77
11.89
12.37
12.84
13.73
14.1
11.73
11.16
14.1
15.43
15.5
14.83
14.53
Revenue per Share
1.22
1.02
1.55
1.51
1.66
1.86
1.98
2.21
2.42
2.63
1.44
1
1.88
2.42
2.25
1.73
1.53
Basic EPS, GAAP
1.27
0.72
0.05
-0.21
1.91
0.95
1.17
1.03
1.43
1.56
7.11
0.6
2.36
2.53
2.21
1.25
1.28
Free Cash Flow per Basic Share
0.66
0.73
0.61
0.93
0.91
1
1.12
1.19
1.33
1.46
1.58
0.87
0.6
1.13
1.46
1.37
- -
Dividend per Share
5.19
5.29
6.22
6.8
7.55
8.44
9.3
10.33
11.52
12.69
12.55
12.67
13.83
15.1
15.89
16.28
15.51
Book Value per Share
6.06
6.29
7.17
7.77
8.57
9.48
10.41
11.46
12.66
13.86
13.62
13.69
15.03
16.3
17.12
17.54
16.77
Tangible Book Value per Share
160
160
160
160
160
160
160
160
160
160
160
160
160
160
160
160
160
Basic Weighted Avg Shares
1,383
1,449
1,721
1,781
1,883
1,902
1,979
2,054
2,198
2,256
1,876
1,786
2,255
2,472
2,484
2,372
2,325
Sales/Revenue/Turnover
17.97
16.2
17.82
16.23
17.13
19.06
19.56
20.92
23.01
22.54
14.41
10.68
16.43
19.08
17.33
13.64
12.23
Operating Margin (%)
95
101
115
134
139
141
135
134
136
137
143
167
186
179
190
202
205
Depreciation Expense
194
163
248
241
265
298
317
354
387
421
231
159
301
388
361
277
244
Net Income, GAAP
24.43
30.71
22.83
19.86
19.8
19.94
18.03
17.61
17.88
18.14
16.57
18.06
19.84
19.76
19.73
19.84
19.73
Effective Tax Rate (%)
14.06
11.23
14.39
13.54
14.09
15.68
16.03
17.24
17.6
18.64
12.3
8.92
13.33
15.69
14.52
11.67
10.51
Profit Margin (%)
120
86
189
-159
-11
197
304
479
762
1,011
940
822
1,109
1,022
971
1,316
1,357
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1,004
1,036
1,187
1,280
1,400
1,543
1,684
1,847
2,037
2,225
2,203
2,223
2,431
2,634
2,761
2,817
2,695
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
24.71
19.4
26.88
21.6
21.83
23.32
22.36
22.55
22.13
21.71
11.43
7.9
14.18
16.74
14.53
10.75
10
Return on Capital (%)
24.71
19.4
26.88
23.15
23.11
23.32
22.36
22.55
22.13
21.71
11.43
7.9
14.18
16.74
14.53
10.75
10
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
160
Market Capitalization
3,968
3,680
3,504

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1,369
1,591
1,781
Cash, Cash Equivalents & STI
1,055
1,262
1,483
Accounts Receivable, Net
235
241
198
Inventories
52
60
68
Total Current Liabilities
278
275
424
Payables & Accruals
271
267
416
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.28%
5.09%
2.05%
Free Cash Flow
57.02%
31.08%
-43.68%
Net Income, GAAP
4.72%
11.28%
-23.28%
Sales/Revenue/Turnover
2.77%
5.41%
-4.51%
Total Cash Common Dividend
8.34%
7.08%
-6.16%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
601
585
695
604
2,484
2025
582
573
614
603
2,372
2026
535
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.54
0.47
0.79
- -
2.25
2025
0.48
0.35
0.47
- -
1.73
2026
0.28
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.46
2025
- -
- -
- -
- -
1.37
2026
- -
- -
- -
- -
- -
Similar Companies
ShareHope Medicine Co., Ltd. (8403.TWO)
Astrana Health, Inc. (ASTH)
Orpea S.A. (ORPEF)
First Choice Healthcare Solutions, Inc. (FCHS)
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR)
Concord Medical Services Holdings Limited (CCM)
Business
Nonthavej Hospital Public Company Limited (NTV.BK) operates as a tertiary care private hospital in Thailand, providing comprehensive medical services to inpatients and outpatients, including 24-hour emergency care, ambulance transport nationwide, and specialized health check-up programs both on-site and via mobile digital X-ray units. The hospital offers treatments across numerous centers and clinics, such as laparoscope surgery, breast cancer care, children and teens services, neurology, dental, diabetes management, diagnostic digital imaging, gastrointestinal and liver conditions, general medicine, gynecologic cancer treatment, gynecological laparoscopic surgery, hemodialysis, ICU and CCU facilities, minimally invasive surgery, nephrology, orthopedics, pain clinic, physical medicine and rehabilitation, pregnancy care, respiration, skin and cosmetic surgery, sleep lab, vascular services, eye-ear-nose-throat care, and wellness programs; it maintains 208 inpatient beds, 90 outpatient examination rooms serving up to 2,000 patients daily with 24-hour clinic access, and advanced technologies including 3D full high-definition laparoscopic surgery, 192-slice CT scan, microscope-assisted procedures, mechanical thrombectomy, varicose vein catheter treatments, fibro scan, and radiofrequency ablation. Founded in 1981 as the first private hospital in Nonthaburi province and listed on the Stock Exchange of Thailand in 1994, Nonthavej is headquartered at 432 Ngamwongwan Road, Bang Khen, Muang District, Nonthaburi, with operations focused on the Thai market and accreditations including Joint Commission International (JCI), Hospital Accreditation (HA), Good Practice of Endometriosis, ISO 15189:2007 medical laboratory standards, GMP/HACCP patient food safety, and ISO 50001:2011 energy management. Recent developments include the hospital's 44th anniversary NTV Health Expo in September 2025 promoting health programs, sustained revenue growth to 2.50 billion baht in 2024 with net income of 360.74 million baht, quarterly financial reporting through 2025 including management discussions and analysis for Q3 2025, and ongoing JCI re-accreditation efforts emphasizing medical personnel development and cutting-edge technology investments.